… Patients with follicular lymphoma (FL) can have high response rates to early lines of …
subdivided by histology, with follicular lymphoma (FL) and marginal zone lymphoma (MZL) being …

… There are currently two Food and Drug Administration (FDA)-approved PI3K inhibitors for
the treatment of R/R FL in patients who have failed two prior lines of therapy: idelalisib and …

… in a randomized front-line study and, when combined with rituximab, … Patients staged with
FDG-PET prior to RT have a more … stage patients staged with FDG PET prior to RT reported a 3-…

… with follicular lymphoma (FL) frequently require multiple treatments during their disease course;
however, survival based on lines of … of Burkitt lymphoma, transformation occurred prior to …

… intensity of prior therapy and actual lymphoma manifestations … standard of care for first-line
therapy of patients achieving first … first-line treatment for advanced follicular lymphoma. Blood …

… poor outcomes to first-line therapy (m7–Follicular Lymphoma International Prognostic Index
[… , number and types of prior therapies, and efficacy of prior therapies. AlloSCT, allogeneic …

… The choice of R-CHOP or R-CVP was determined by an investigator prior to randomization.
… CVP as firstline treatment for advanced follicular lymphoma. Blood 105:14171423, 2005 …

… Integration of gene mutations in risk prognostication for patients receiving first-line
immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial …

… observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation
in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized …

… 2 prior lines of therapy. The most exciting data currently involve immune attack against follicular
lymphoma … the promise of improving outcomes and possibly cure of follicular lymphoma. …